The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March

The Oncology Institute (NASDAQ: TOI) announced executive participation in three investor conferences in March 2026.

Rhea-AI Summary

The Oncology Institute (NASDAQ: TOI) announced executive participation in three investor conferences in March 2026. Presentations include Jefferies Healthcare Services Innovation & Technology Summit and Leerink Global Healthcare Conference on March 9 in Miami, and Oppenheimer MedTech & Services Conference (virtual) on March 16.

Presenters include Dr. Daniel Virnich, CEO, and Rob Carter, CFO; webcasts and replays will be available via the company Investor Relations site.

Argus Feb 25 session

+10.85% close to close Open Argus

Details

News Market Reaction – TOI

In the Feb 25 session, TOI gained 10.85%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +10.8% in the session following this news. A strong positive reaction aligns with a...

Analysis

The stock surged +10.8% in the session following this news. A strong positive reaction aligns with a company already trading below its 200-day moving average of $3.33, as investors may have welcomed additional visibility from multiple March conferences. Historical reactions to governance and strategic news have been mixed, so a large upside move could reflect recalibrated expectations rather than a structural shift, and past volatility around announcements has been notable.

Key Figures

Jefferies presentation date: March 9, 2026 Jefferies time window: 11:30 a.m.–12:00 p.m. ET Leerink presentation date: March 9, 2026 +5 more

Jefferies presentation date

March 9, 2026

Jefferies Healthcare Services Innovation & Technology Summit

Jefferies time window

11:30 a.m.–12:00 p.m. ET

Conference presentation slot

Leerink presentation date

March 9, 2026

Leerink Global Healthcare Conference

Leerink time window

3:00 p.m.–3:30 p.m. ET

Conference presentation slot

Oppenheimer presentation date

March 16, 2026

Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Oppenheimer time window

10:00 a.m.–10:30 a.m. ET

Virtual conference presentation slot

Oppenheimer edition

36th Annual

Oppenheimer Healthcare MedTech & Services Conference

Pre-news share price

$2.58

Price before February 25, 2026 conference announcement

Historical Context

5 past events · Latest: Feb 23

5 events

1. Feb 23

   Board appointment

   24h Move

   -0.4%

   Experienced healthcare executive appointed to TOI’s Board of Directors.

2. Jan 12

   Guidance & outlook

   24h Move

   -7.9%

   Reaffirmed 2025 guidance and provided preliminary 2026 revenue and EBITDA outlook.

3. Jan 9

   Leadership promotions

   24h Move

   -3.0%

   Promotions of CIO and CPO to support technology and people strategy.

4. Jan 2

   Board addition

   24h Move

   +6.8%

   Addition of experienced CFO from another healthcare company to the Board.

5. Dec 1

   Board resignation

   24h Move

   -6.4%

   Resignation of Board member and initiation of search for new directors.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will participate in several investor conferences in March.

Details for the conferences are as follows:

• Jefferies Healthcare Services Innovation & Technology Summit
  Presentation: Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ET
  Location: Miami, FL
  Presenter: Dr. Daniel Virnich, Chief Executive Officer
• Leerink Global Healthcare Conference
  Presentation: Monday, March 9, 2026, from 3:00 p.m. to 3:30 p.m. ET
  Location: Miami, FL
  Presenter: Rob Carter, Chief Financial Officer
• Oppenheimer 36th Annual Healthcare MedTech & Services Conference
  Presentation: Monday, March 16, 2026, from 10:00 a.m. to 10:30 a.m. ET
  Location: Virtual
  Presenters: Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer
  

Where available, live webcasts and replays of the presentations will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.

About The Oncology Institute (www.theoncologyinstitute.com):

Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors
ICR Healthcare
TOI@icrhealthcare.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will The Oncology Institute (TOI) present at the Jefferies Healthcare Services Innovation & Technology Summit?

The presentation is scheduled for Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ET. According to the company, Dr. Daniel Virnich, CEO, will present in Miami, and a live webcast or replay will be available on the company's Investor Relations site.

What time is The Oncology Institute (TOI) presenting at the Leerink Global Healthcare Conference on March 9, 2026?

TOI will present on Monday, March 9, 2026, from 3:00 p.m. to 3:30 p.m. ET. According to the company, Rob Carter, CFO, will be the presenter in Miami and the presentation will be accessible via the Investor Relations webcasts when available.

Who will represent The Oncology Institute (TOI) at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference?

Dr. Daniel Virnich, CEO, and Rob Carter, CFO, will present at the Oppenheimer conference on Monday, March 16, 2026, from 10:00 a.m. to 10:30 a.m. ET. According to the company, that session will be held virtually with webcast access via Investor Relations.

Will The Oncology Institute (TOI) provide webcasts or replays of the March 2026 investor presentations?

Yes. Webcasts and replays will be available where provided, accessible through the company's Investor Relations website. According to the company, presentations that offer live streams will later have replays posted at https://investors.theoncologyinstitute.com/.

Which executives from The Oncology Institute (TOI) will present at investor conferences in March 2026?

The announced presenters are Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer. According to the company, Virnich will present at Jefferies and Oppenheimer, while Carter will present at Leerink and co-present at Oppenheimer.

Where and when is The Oncology Institute (TOI) hosting its March 9, 2026 investor presentations?

Both March 9, 2026 presentations will be held in Miami, Florida: Jefferies at 11:30 a.m.–12:00 p.m. ET and Leerink at 3:00 p.m.–3:30 p.m. ET. According to the company, each session will list webcast details on its Investor Relations page.